Free CME from PeerView


Pulmonary/Respiratory Medicine CME

Medical Learning Institute, Inc.
Everything You Need to Know About Molecular Testing and Targeted Therapies in NSCLC: Essential Guidance for Modern Patient-Centered Precision Lung Cancer Care
Suresh S. Ramalingam, MD, FACP, FASCO
November 30, 2020
Medical Learning Institute, Inc.
Improving Recognition and Management of EGPA: A Multidisciplinary Approach to Individualizing Treatment
Eric Gapud, MD, PhD
November 30, 2020
Medical Learning Institute, Inc.
The Evolving Treatment Landscape of SSc-ILD: Strategies to Improve Recognition and Management
Flavia Castelino, MD
November 25, 2020
Kristen Ganjoo, MD
PeerView Institute
Solutions for Tenosynovial Giant Cell Tumors: Employing Effective Multimodal and Multidisciplinary Approaches to Patient Care
Robin L. Jones, MD
November 20, 2020
Jarushka Naidoo, MB, BCH, MHS / Andrew Stolbach, MD, MPH
PeerView Institute
Emergency Department on Alert: Solving Oncologic Emergency Quandaries During the Immuno-Oncology Era and COVID-19 Pandemic
Jarushka Naidoo, MB, BCH, MHS / Andrew Stolbach, MD, MPH
November 20, 2020
PeerView Institute
Modernizing Your Radiation Oncology Practice With Tumor Treating Fields and Other Novel Multimodal Strategies: Understanding the Science, Evidence, and Practical Aspects Across a Range of Solid Tumors
Hani M. Babiker, MD
November 12, 2020
Stephen V. Liu, MD <br> Bhavesh Shah, RPh, BCOP
PeerView Institute
Immunotherapy in the Treatment Arsenal for Small Cell Lung Cancer, and Managed Care Implications for the Four Ps: Patient, Provider, Pharmacy, and Plan
Stephen V. Liu, MD
Bhavesh Shah, RPh, BCOP
November 12, 2020
PeerView Institute
Addressing Challenges in the Treatment of Nontuberculous Mycobacterial Lung Disease: Managing Adverse Effects to Keep Patients on Therapy
Gwen A. Huitt, MD, MS
November 9, 2020
Kathleen N. Moore, MD, MS / Kristi Jhangiani, PharmD, BCPS
PeerView Institute
Managed Care Implications of the Expanding Role of PARP Inhibitors in Oncology: Evolving Evidence Base, Current Value Assessment Frameworks, and Considerations for Decision-Making in Managed Care Settings
Kathleen N. Moore, MD, MS / Kristi Jhangiani, PharmD, BCPS
November 6, 2020
PeerView Institute
Progressive Pathways: Recent Recommendations and Emerging Therapies for Treating NF1-Associated Tumors
Roger J. Packer, MD
November 5, 2020
Medical Learning Institute, Inc.
Reducing the Burden of Influenza on Children: An Exploration of Novel and Emerging Antiviral Therapy
Jesse Papenburg, MD, MSc, FRCPC
October 8, 2020
Medical Learning Institute, Inc.
Differential Diagnosis of Interstitial Lung Diseases: Interpreting HRCT Accurately and Working With a Multidisciplinary Approach
August 21, 2020
Medical Learning Institute, Inc.
Building on Progress to Further Advance Care for Patients With EGFR Mutation–Positive NSCLC: A Look at Emerging Precision Medicine Strategies Encompassing Acquired Resistance, Treatment Sequencing, and Patient Considerations
Edward Garon, MD, MS
August 10, 2020
Medical Learning Institute, Inc.
Moving in Leaps and Bounds Toward Expanded Precision Treatment of HER2- or HER3-Driven Breast, Gastrointestinal, Lung, and Other Cancers: Current Challenges, Opportunities for Improvement, and Practical Considerations
Erika Hamilton, MD
August 6, 2020
Medical Learning Institute, Inc.
Finding the Path to Improved Outcomes in Uncontrolled Persistent Asthma: Applying the Latest Clinical Evidence for Treatment Success
Cedric "Jamie" Rutland, MD
July 28, 2020
Medical Learning Institute, Inc.
Coronavirus Disease 2019 (COVID-19): Need-to-Know Information and Practical Guidance for Healthcare Professionals on the Front Lines of Patient Care
Paul E. Sax, MD
July 24, 2020
Medical Learning Institute, Inc.
Everything You Need to Know About Biomarkers, Immunotherapies, Combinations, and Other Emerging Approaches for Lung Cancer
Suresh S. Ramalingam, MD, FACP, FASCO
July 14, 2020
Medical Learning Institute, Inc.
Immunotherapy as a Component of Multimodal Therapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Evidence, and Implications for the Multidisciplinary Team
Brendon Stiles, MD
June 25, 2020
Medical Learning Institute, Inc.
Improving Outcomes for Patients With Nontuberculous Mycobacterial Lung Disease: Navigating the Complexities of Diagnosis and Management
Kevin Winthrop, MD, MPH
June 23, 2020
Medical Learning Institute, Inc.
Chair's Take: Everything You Need to Know About Biomarkers, Immunotherapies, Combinations, and Other Emerging Approaches for Lung Cancer
Suresh S. Ramalingam, MD, FACP, FASCO
June 15, 2020
Medical Learning Institute, Inc.
Chair's Take on Immunotherapy as a Component of Multimodal Therapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Evidence, and Implications for the Multidisciplinary Team
Brendon Stiles, MD
June 10, 2020
Robin Lachmann, MD, PhD / Melissa Wasserstein, MD
Medical Learning Institute, Inc.
Assessing the Potential Role of Emerging Therapies in the Early Diagnosis and Optimal Management of Chronic Visceral Acid Sphingomyelinase Deficiency
Robin Lachmann, MD, PhD / Melissa Wasserstein, MD
June 3, 2020
Medical Learning Institute, Inc.
Improving Outcomes in Patients With Molecularly Altered NSCLC Through Broad Implementation of Precision Testing and Treatment: Latest Evidence and Practical Guidance in the Context of a Changing Targeted Therapy Landscape
Alexander Drilon, MD
April 30, 2020
Medical Learning Institute, Inc.
Overcoming Challenges in the Treatment of Influenza: Examining the Underuse of Antiviral Therapies and Exploring Novel Approaches
Michael G. Ison, MD, MS, FIDSA, FAST
March 26, 2020
Purdue University College of Pharmacy
Overcoming Challenges Associated With the Diagnosis and Management of EGPA: An Exploration of Novel Approaches
Praveen Akuthota, MD
February 18, 2020

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView